DLD develops, markets and provides scientific service for high quality innovative tests for in-vitro-diagnosis. The products range includes so-called „niche tests” for autoimmune diseases, cardiovascular diseases, cancer diseases and renal dysfunction. The methodology of the tests is chiefly based on immunoassay techniques such as Radioimmunoassays (RIA) and Enzyme immunoassays (ELISA).
DLD stands for innovative products and high level research and development in cooperation with several study groups.
Products: Immunoassays: Elisa Kit/EIA Kit.
For more information, please visit: www.dld-diagnostika.de